Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Dipeptidyl peptidase IV (DPP IV, CD26) in patients with mental eating disorders.

Hildebrandt M, Rose M, Mayr C, Arck P, Schüler C, Reutter W, Salama A, Klapp BF.

Adv Exp Med Biol. 2000;477:197-204.

PMID:
10849747
2.

Alterations in expression and in serum activity of dipeptidyl peptidase IV (DPP IV, CD26) in patients with hyporectic eating disorders.

Hildebrandt M, Rose M, Mayr C, Schüler C, Reutter W, Salama A, Klapp BF.

Scand J Immunol. 1999 Nov;50(5):536-41.

3.

Eating disorders: a role for dipeptidyl peptidase IV in nutritional control.

Hildebrandt M, Rose M, Mönnikes H, Reutter W, Keller W, Klapp BF.

Nutrition. 2001 Jun;17(6):451-4.

PMID:
11399402
4.

DPP IV, immune parameters, and psychometrical variables in patients with eating disorders.

Fliege H, Rose M, Klapp BF, Hildebrandt M.

Adv Exp Med Biol. 2003;524:313-20. No abstract available.

PMID:
12675253
5.

Lowered serum dipeptidyl peptidase IV activity in patients with anorexia and bulimia nervosa.

van West D, Monteleone P, Di Lieto A, De Meester I, Durinx C, Scharpe S, Lin A, Maj M, Maes M.

Eur Arch Psychiatry Clin Neurosci. 2000;250(2):86-92.

PMID:
10853924
6.

Dipeptidyl peptidase IV (DP IV, CD26) in patients with inflammatory bowel disease.

Hildebrandt M, Rose M, Rüter J, Salama A, Mönnikes H, Klapp BF.

Scand J Gastroenterol. 2001 Oct;36(10):1067-72.

PMID:
11589380
7.

Higher serum DPP-4 enzyme activity and decreased lymphocyte CD26 expression in type 1 diabetes.

Varga T, Somogyi A, Barna G, Wichmann B, Nagy G, Rácz K, Selmeci L, Firneisz G.

Pathol Oncol Res. 2011 Dec;17(4):925-30. doi: 10.1007/s12253-011-9404-9. Epub 2011 Jul 22.

PMID:
21785903
8.

Dipeptidyl-peptidase IV-beta, a novel form of cell-surface-expressed protein with dipeptidyl-peptidase IV activity.

Jacotot E, Callebaut C, Blanco J, Krust B, Neubert K, Barth A, Hovanessian AG.

Eur J Biochem. 1996 Jul 15;239(2):248-58.

9.

Dipeptidyl peptidase IV (CD26) activity in human alloreactive T cell subsets varies with the stage of differentiation and activation status.

Ruiz P, Hao L, Zucker K, Zacharievich N, Viciana AL, Shenkin M, Miller J.

Transpl Immunol. 1997 Jun;5(2):152-61.

PMID:
9269038
10.
11.

Dipeptidyl-peptidase IV-beta--further characterization and comparison to dipeptidyl-peptidase IV activity of CD26.

Blanco J, Nguyen C, Callebaut C, Jacotot E, Krust B, Mazaleyrat JP, Wakselman M, Hovanessian AG.

Eur J Biochem. 1998 Sep 1;256(2):369-78.

12.

Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.

Buljevic S, Detel D, Pucar LB, Mihelic R, Madarevic T, Sestan B, Varljen J.

Rheumatol Int. 2013 Nov;33(11):2867-74. doi: 10.1007/s00296-013-2823-z. Epub 2013 Jul 18.

PMID:
23864142
13.

CD26/DPP IV in experimental and clinical organ transplantation.

Korom S, de Meester I, Belyaev A, Schmidbauer G, Schwemmle K.

Adv Exp Med Biol. 2003;524:133-43.

PMID:
12675233
14.

Human miscarriage is associated with increased number of CD26 decidual lymphocytes.

Sehmsdorf US, Zenclussen AC, Arck P, Hertwig K, Joachim RA, Klapp B, Hildebrandt MO.

Scand J Immunol. 2004 Apr;59(4):400-7.

15.

CD26/dipeptidyl-peptidase IV and adenosine deaminase serum levels in psoriatic patients treated with cyclosporine, etanercept, and psoralen plus ultraviolet A phototherapy.

Yıldırım FE, Karaduman A, Pinar A, Aksoy Y.

Int J Dermatol. 2011 Aug;50(8):948-55. doi: 10.1111/j.1365-4632.2010.04799.x.

PMID:
21781066
16.

Expression of the rat CD26 antigen (dipeptidyl peptidase IV) on subpopulations of rat lymphocytes.

Gorrell MD, Wickson J, McCaughan GW.

Cell Immunol. 1991 Apr 15;134(1):205-15.

PMID:
1672835
17.

Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients.

Uematsu T, Urade M, Yamaoka M, Yoshioka W.

J Oral Pathol Med. 1996 Oct;25(9):507-12.

PMID:
8959560
18.

Inhibition of CD26/dipeptidyl peptidase IV activity in vivo prolongs cardiac allograft survival in rat recipients.

Korom S, De Meester I, Stadlbauer TH, Chandraker A, Schaub M, Sayegh MH, Belyaev A, Haemers A, Scharpé S, Kupiec-Weglinski JW.

Transplantation. 1997 May 27;63(10):1495-500.

PMID:
9175816
19.

CD26 Expression on T Helper Populations and sCD26 Serum Levels in Patients with Rheumatoid Arthritis.

Cordero OJ, Varela-Calviño R, López-González T, Calviño-Sampedro C, Viñuela JE, Mouriño C, Hernández-Rodríguez Í, Rodríguez-López M, Aspe de la Iglesia B, Pego-Reigosa JM.

PLoS One. 2015 Jul 15;10(7):e0131992. doi: 10.1371/journal.pone.0131992. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0139535. Pego, José María [corrected to Pego-Reigosa, José María].

20.

Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity.

Blanco J, Jacotot E, Callebaut C, Krust B, Hovanessian AG.

Adv Exp Med Biol. 1997;421:193-9. Review.

PMID:
9330697

Supplemental Content

Support Center